Ifosfamide

"Ifosfamide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent.

Descriptor ID	D007069
MeSH Number(s)	D02.455.526.728.650.730.243.250 D02.705.672.500.243.250 D03.383.533.500
Concept/Terms	Ifosfamide Ifosfamide Isofosfamide Isophosphamide Iphosphamide Iso-Endoxan Iso Endoxan Holoxan Holoxan NSC-109,724 NSC-109,724 NSC 109,724 NSC109,724 NSC-109724 NSC 109724 NSC109724 Asta Z 4942 Asta Z 4942

Below are MeSH descriptors whose meaning is more general than "Ifosfamide".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Hydrocarbons [D02.455]
Hydrocarbons, Halogenated [D02.455.526]
Mustard Compounds [D02.455.526.728]
Nitrogen Mustard Compounds [D02.455.526.728.650]
Phosphoramide Mustards [D02.455.526.728.650.730]
Cyclophosphamide [D02.455.526.728.650.730.243]
Ifosfamide [D02.455.526.728.650.730.243.250]
Organophosphorus Compounds [D02.705]
Phosphoramides [D02.705.672]
Phosphoramide Mustards [D02.705.672.500]
Cyclophosphamide [D02.705.672.500.243]
Ifosfamide [D02.705.672.500.243.250]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Oxazines [D03.383.533]
Ifosfamide [D03.383.533.500]

Below are MeSH descriptors whose meaning is related to "Ifosfamide".

Below are MeSH descriptors whose meaning is more specific than "Ifosfamide".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Ifosfamide" by people in this website by year, and whether "Ifosfamide" was a major or minor topic of these publications.

Bar chart showing 7 publications over 5 distinct years, with a maximum of 2 publications in 2003 and 2010

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
2000	1	1
2003	2	2
2004	1	1
2005	1	1
2010	2	2

Below are the most recent publications written about "Ifosfamide" by people in Profiles.

Evens AM, Carson KR, Kolesar J, Nabhan C, Helenowski I, Islam N, Jovanovic B, Barr PM, Caimi PF, Gregory SA, Gordon LI. A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma. Ann Oncol. 2013 Dec; 24(12):3076-81.

View in: PubMed
Clement J, Varlotto J, Rybka W, Frauenhoffer E, Drabick JJ. Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation. J Clin Oncol. 2013 Jul 01; 31(19):e316-9.

View in: PubMed
Moskowitz AJ, Yahalom J, Kewalramani T, Maragulia JC, Vanak JM, Zelenetz AD, Moskowitz CH. Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Blood. 2010 Dec 02; 116(23):4934-7.

View in: PubMed
Moskowitz CH, Yahalom J, Zelenetz AD, Zhang Z, Filippa D, Teruya-Feldstein J, Kewalramani T, Moskowitz AJ, Rice RD, Maragulia J, Vanak J, Trippett T, Hamlin P, Horowitz S, Noy A, O'Connor OA, Portlock C, Straus D, Nimer SD. High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging. Br J Haematol. 2010 Mar; 148(6):890-7.

View in: PubMed
Quesenberry CD, Li C, Chen AH, Zweizig SL, Ball HG. Primary angiosarcoma of the ovary: a case report of Stage I disease. Gynecol Oncol. 2005 Oct; 99(1):218-21.

View in: PubMed
Kewalramani T, Zelenetz AD, Nimer SD, Portlock C, Straus D, Noy A, O'Connor O, Filippa DA, Teruya-Feldstein J, Gencarelli A, Qin J, Waxman A, Yahalom J, Moskowitz CH. Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood. 2004 May 15; 103(10):3684-8.

View in: PubMed
Hamlin PA, Zelenetz AD, Kewalramani T, Qin J, Satagopan JM, Verbel D, Noy A, Portlock CS, Straus DJ, Yahalom J, Nimer SD, Moskowitz CH. Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. Blood. 2003 Sep 15; 102(6):1989-96.

View in: PubMed
Zelenetz AD, Hamlin P, Kewalramani T, Yahalom J, Nimer S, Moskowitz CH. Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma. Ann Oncol. 2003; 14 Suppl 1:i5-10.

View in: PubMed
Kewalramani T, Zelenetz AD, Hedrick EE, Donnelly GB, Hunte S, Priovolos AC, Qin J, Lyons NC, Yahalom J, Nimer SD, Moskowitz CH. High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis. Blood. 2000 Oct 01; 96(7):2399-404.

View in: PubMed

People

Explore

Similar Concepts

Top Journals